NO20043634L - Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister - Google Patents

Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister

Info

Publication number
NO20043634L
NO20043634L NO20043634A NO20043634A NO20043634L NO 20043634 L NO20043634 L NO 20043634L NO 20043634 A NO20043634 A NO 20043634A NO 20043634 A NO20043634 A NO 20043634A NO 20043634 L NO20043634 L NO 20043634L
Authority
NO
Norway
Prior art keywords
ester
mono
dopamine
asymmetrically substituted
receptor agonists
Prior art date
Application number
NO20043634A
Other languages
English (en)
Norwegian (no)
Inventor
Durk Dijkstra
Hakan Wikstrom
Original Assignee
Darpharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0200478A external-priority patent/SE0200478D0/xx
Priority claimed from SE0200474A external-priority patent/SE0200474D0/xx
Application filed by Darpharma Inc filed Critical Darpharma Inc
Publication of NO20043634L publication Critical patent/NO20043634L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20043634A 2002-02-15 2004-08-31 Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister NO20043634L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0200478A SE0200478D0 (sv) 2002-02-15 2002-02-15 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine D1 receptor agonist A-86929
SE0200474A SE0200474D0 (sv) 2002-02-17 2002-02-17 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine D1 receptor agonists Dihydrexidine and Dinapsoline
PCT/US2003/004592 WO2003070245A1 (fr) 2002-02-15 2003-02-14 Promedicaments a base de monoester et de diester a substitution asymetrique des agonistes des recepteurs d1 de la dopamine

Publications (1)

Publication Number Publication Date
NO20043634L true NO20043634L (no) 2004-11-11

Family

ID=27759833

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043634A NO20043634L (no) 2002-02-15 2004-08-31 Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister

Country Status (11)

Country Link
US (1) US7220754B2 (fr)
EP (1) EP1480647B1 (fr)
JP (1) JP2005526728A (fr)
AT (1) ATE406896T1 (fr)
AU (1) AU2003217430B2 (fr)
CA (1) CA2476115A1 (fr)
DE (1) DE60323339D1 (fr)
DK (1) DK1480647T3 (fr)
ES (1) ES2314189T3 (fr)
NO (1) NO20043634L (fr)
WO (1) WO2003070245A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9046537B2 (en) 2003-09-22 2015-06-02 Enzo Biochem, Inc. Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
WO2005062894A2 (fr) * 2003-12-23 2005-07-14 Darpharma, Inc. Co-administration de composes de liaison au recepteur de la dopamine
US9052324B2 (en) 2004-05-19 2015-06-09 Enzo Biochem, Inc. Compounds and assays for controlling Wnt activity
US8596306B2 (en) * 2005-10-27 2013-12-03 Synthetic Gas Solutions, Llc Perfluorocarbon gas insufflation
WO2007098462A2 (fr) * 2006-02-21 2007-08-30 Purdue Research Foundation Synthèse et méthodes d'utilisation de chroménoisoquinolines trans-fusionnées
WO2010124005A1 (fr) 2009-04-21 2010-10-28 Purdue Research Foundation Modulateurs octahydrobenzoisoquinoléines de récepteurs de la dopamine, et utilisations de ces modulateurs
ES2649144T3 (es) * 2012-11-08 2018-01-10 Pfizer Inc. Compuestos heteroaromáticos y su uso como ligandos de dopamina D1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282227A (en) 1980-05-22 1981-08-04 Smithkline Corporation Renal vasodilating 3,4-dihydroxyphenyltetrahydrothienopyridines
US4340600A (en) 1980-05-22 1982-07-20 Smithkline Corporation Renal dilating methods and compositions using 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines
JPH02138A (ja) * 1987-09-18 1990-01-05 Banyu Pharmaceut Co Ltd Ｌ‐ドーパ誘導体
US5047536A (en) * 1989-03-17 1991-09-10 Purdue Research Foundation Hexahydrobenzo(A)phenanthridine compounds
IE912999A1 (en) 1990-09-07 1992-03-11 Abbott Lab Phenanthridine compounds
KR100292928B1 (ko) * 1992-05-26 2001-11-05 프란시스 제이 메이어 치환된헥사하이드로벤조페난트리딘
JP2710695B2 (ja) * 1993-04-06 1998-02-10 アボツト・ラボラトリーズ ドーパミンアゴニストとしての四環式化合物
JPH10502923A (ja) * 1994-07-15 1998-03-17 パーデュー・リサーチ・ファンデーション ジヒドレキシジンおよびその置換類似体の光学活性異性体
ES2169257T3 (es) 1995-08-18 2002-07-01 Purdue Research Foundation Nuevas isoquinolinas fusionadas como ligandos del receptor de la dopamina.

Also Published As

Publication number Publication date
WO2003070245B1 (fr) 2004-05-27
EP1480647A4 (fr) 2005-07-13
EP1480647B1 (fr) 2008-09-03
AU2003217430B2 (en) 2008-10-23
ES2314189T3 (es) 2009-03-16
EP1480647A1 (fr) 2004-12-01
DE60323339D1 (de) 2008-10-16
CA2476115A1 (fr) 2003-08-28
ATE406896T1 (de) 2008-09-15
JP2005526728A (ja) 2005-09-08
WO2003070245A1 (fr) 2003-08-28
US7220754B2 (en) 2007-05-22
US20050096469A1 (en) 2005-05-05
DK1480647T3 (da) 2009-01-26
AU2003217430A1 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
CY1112941T1 (el) Δικυκλικοι αναστολεις της μεκ
NZ514409A (en) C7 ester substituted taxanes as antitumor agents
CR9587A (es) Derivados de piridazina
NO20062098L (no) Faststofftilstandmontelukast
MX2007004699A (es) Derivados de indol y bencimidazol.
BR9904162A (pt) 4-carboxiamino-2-metil-1,2,3,4-tetra-hidroquinolinas aneladas
IL204594A (en) Protein kinase inhibitors
BRPI0506477A (pt) compostos farmaceuticamente úteis e inovadores
BR0308979A (pt) Derivados de indolilmaleimida
BG105428A (en) 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
UA70960C2 (uk) 4-амінозаміщені-2-заміщені-1,2,3,4-тетрагідрохіноліни як інгібітори протеїну, який переносить холестериловий етер
ECSP014097A (es) Derivados de tiofeno utiles como agentes anticancerosos
DK1753723T3 (da) Substituerede quinolinderivater som mitotiske kinesininhibitorer
CY1109055T1 (el) 11-((4r,6r)-4,5,6-τριϋδροξυ-3-(r)-υδροξυ-εξυλοκαρβαμοϋλο)-ενδεκαϊνικο οξυ
MA26769A1 (fr) Derives de thioamide.
CY1110034T1 (el) Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
IN266803B (fr)
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
UY30787A1 (es) "inhibidores benzoimidazolicos de trpv1"
NO20043634L (no) Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister
DE60002733D1 (de) Diester prodrugs von decahydroischinoline-3-carbonsäure
WO2003057205A3 (fr) Combinaison d'inhibiteurs de mtp ou d'inhibiteurs de secretions apob avec des fibrates en vue d'une utilisation comme medicament
DE60222131D1 (de) Neues alkaloidderivat und dieses enthaltende pharmazeutische zusammensetzung
TW200724168A (en) Pharmaceutical compositions
HRP20080546T3 (en) Combination of an antagonist of the tp-receptors and clopidogrel